Industry News

Is The Creation Of An EU HTA Agency A Realistic Scenario?

Identifying And Selecting New Procedures For Health Technology Assessment

Why Is Observational CER Gaining Popularity In China?

How Can Wearables Help In MS Trials?

Can NICE Get Any More Restrictive?

Market Access Risk Scores Update From iHS

How Low Can The French Government Negotiate Price For Sovaldi?

Complete This Survey On Formulary Decision Making And Receive A $100 Gift Certificate!

Why Is The AMCP Opposed To Restricting Drug Tiers and Pricing?

How Many Ways Are You Using Digital Marketing To Reach Doctors?

Old Foes Or New Friends – Obama & US Health Insurers

Data & Decision Making From Evidence Soup

Boehringer Ingelheim, WellPoint and HealthCore Announce Multi-Year Research Collaboration

How Well Do You Understand The Fundamentals Of Economic Evaluation?

Have Recent Increases in Generic Drug Prices Affected You?

4 Tips For Success in Literature Reviews

How Are Medical Devices Being Evaluated In Germany?

What Vital Cancer Drugs Are Facing The English Axe?

Could Biosimilar Drugs Save U.S. Healthcare?

Check Out The Health Economics and Decision Science (HEDS) Winter Newsletter

What Is Your Opinion On Informed Consent Rules In Comparison Studies – We Want To Know!

New Draft Guidelines Involving Risks In Comparative-Effectiveness Research – A Confusing Clarification

How Are High-Cost Generic Drugs Affecting Patients And Policymakers?

Texas Health Insurance Plans Differ Widely In Cost, Coverage and Hospital Access Across the State

Will High Demand For Ebola Vaccine Mean High Prices?

28% Of Employees Are Dissatisfied With Training & Development Opportunities – We’ve Got A Fix!

Outcome-Based Data And Value Are Vital For Payers And HTAs

Can Clinical Genome Sequencing Tests Overcome Reimbursement Barriers?

Is Your Real World Evidence Study In The Weeds?

Should There Be Risk Adjustment In Incentive Payments For The Use Of Generic Medications?


Stay Connected